Larvol Delta - A-firstinhuman-study-of-VG161-in-participants-with-advanced-malignant-tumours-that-have-not-responded-to-conventional-therapies

VG161 - ViroGin Biotech

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12620000244909

Sep 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next